Organogenesis Holdings Inc. (ORGO) Earnings History
Annual and quarterly earnings data from 2016 to 2025
Loading earnings history...
ORGO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ORGO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 73.6% | 10.0% | 6.6% |
| 2024 | 76.0% | -0.3% | 0.2% |
| 2023 | 75.4% | 2.9% | 1.1% |
| 2022 | 76.7% | 4.9% | 3.4% |
| 2021 | 75.6% | 15.5% | 20.2% |
Download Data
Export ORGO earnings history in CSV or JSON format
Free sign-in required to download data
Organogenesis Holdings Inc. (ORGO) Earnings Overview
As of May 8, 2026, Organogenesis Holdings Inc. (ORGO) reported trailing twelve-month net income of -$284,000, reflecting +1600.0% year-over-year growth. The company earned $-0.00 per diluted share over the past four quarters, with a net profit margin of 6.6%.
Looking at the long-term picture, ORGO's 5-year EPS compound annual growth rate (CAGR) stands at +0.0%, reflecting modest earnings expansion. The company achieved its highest annual net income of $94M in fiscal 2021.
Organogenesis Holdings Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MDXG ($31M net income, 11.6% margin), NVCR (-$173M net income, -20.8% margin), TELA (-$39M net income, -54.6% margin), ORGO has room to improve margins relative to the peer group. Compare ORGO vs MDXG →
ORGO Earnings vs Peers
Earnings metrics vs comparable public companies
ORGO Historical Earnings Data (2016–2025)
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $37M | +4201.0% | $56M | $0.15 | 6.6% | 10.0% |
| 2024 | $861,000 | -82.6% | -$1M | $-0.01 | 0.2% | -0.3% |
| 2023 | $5M | -68.2% | $13M | $0.04 | 1.1% | 2.9% |
| 2022 | $16M | -83.5% | $22M | $0.12 | 3.4% | 4.9% |
| 2021 | $94M | +446.6% | $72M | $0.70 | 20.2% | 15.5% |
| 2020 | $17M | +144.5% | $27M | $0.15 | 5.1% | 7.9% |
| 2019 | -$39M | +40.3% | -$30M | $-0.44 | -14.8% | -11.4% |
| 2018 | -$65M | -2996.2% | -$52M | $-0.94 | -33.5% | -26.7% |
| 2017 | -$2M | -903.3% | -$5M | $-0.03 | - | - |
| 2016 | $-208,698 | - | $208,698 | $-0.02 | - | - |
See ORGO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ORGO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ORGO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonORGO — Frequently Asked Questions
Quick answers to the most common questions about buying ORGO stock.
Is ORGO growing earnings?
ORGO EPS is $-0.00, with earnings growth accelerating to +1600.0%. This exceeds the 5-year CAGR of +0.0%. TTM net income reached $-284000.00.
What are ORGO's profit margins?
Organogenesis Holdings Inc. net margin is +6.6%, with operating margin at +10.0%. Margins sit within typical range for the sector.
How consistent are ORGO's earnings?
ORGO earnings data spans 2016-2025. The accelerating earnings trend is +1600.0% YoY. Historical data enables comparison across business cycles.